Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Agrify: Q2 Earnings Insights

  Agrify (NASDAQ:AGFY) reported its Q2 earnings results on Wednesday, August 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Agrify posted an EPS of $0.03.
byBenzinga Insights
August 10, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

 

Agrify (NASDAQ:AGFY) reported its Q2 earnings results on Wednesday, August 10, 2022 at 07:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Agrify posted an EPS of $0.03.

Revenue was up $53.61 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.03 which was followed by a 14.29% drop in the share price the next day.

Here’s a look at Agrify’s past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.33 -0.31 -0.30 -0.24
EPS Actual -0.36 -0.36 -0.47 -0.28
Revenue Estimate 25.37M 27.84M 13.91M 9.92M
Revenue Actual 26.02M 25.27M 15.75M 11.82M

To track all earnings releases for Agrify visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Aurora Touts 41% YoY Increase In International Medical Cannabis Q3 Revenue, Expands In Australia Via New Acquisition

By Jelena Martinovic
February 8, 12:04 PM
Canadian medical cannabis company Aurora Cannabis reported its financial and operational results for Q3 2024. Net revenue increased to CAD64.4m ($42m), up from CAD61.1m in the same quarter the previous year. Medical cannabis net revenue rose by 16% to CAD45.1m, representing 70% of Aurora's consolidated net revenue. Gross profit reached CAD19.8m, up from CAD3.7m in Q3 2022, with adjusted gross profit before fair value adjustments increasing to CAD32.4m from CAD28m. The company recorded a CAD25.5m net loss compared to CAD67.2m in the same quarter in the previous year. Adjusted EBITDA came in at CAD4.3m, up from CAD3m. Miguel Martin, CEO of Aurora, said the company's international medical net revenue had seen year-on-year growth of 41%.

ACB